Minireviews
Copyright ©The Author(s) 2024.
World J Gastroenterol. Oct 14, 2024; 30(38): 4194-4210
Published online Oct 14, 2024. doi: 10.3748/wjg.v30.i38.4194
Figure 1
Figure 1 Mechanistic insights into innovative therapeutic approaches for celiac disease. APC: Antigen-presenting cell; IELs: Intraepithelial lymphocytes; IFN: Interferon; IL: Interleukin; MMP: Matrix metalloproteinase; pDC: Pre-dendritic cell; tTG: Tissue transglutaminase; TNF: Tumor necrosis factor.
Figure 2
Figure 2 Emerging therapeutic strategies from Phase 2 trials in celiac disease treatment. CCR9: C-C chemokine receptor type 9; IL: Interleukin; JAK3: Janus kinase 3.